Human Continuum Appoints Dr. Michael Milligan as Chief Medical Officer

Prominent sports medicine expert to oversee innovative extracellular vesicle therapeutics

Published on Feb. 24, 2026

Got story updates? Submit your updates here. ›

Human Continuum Inc., a developer of platelet-derived and plant-based exosome therapeutics and diagnostics, has appointed Dr. Michael Milligan, MD, MBA, as its Chief Medical Officer. Dr. Milligan brings over 25 years of clinical, leadership, and research experience in sports injuries, musculoskeletal, and orthopedic medicine.

Why it matters

As the company advances its platform of exosome-based solutions for longevity, orthopedics, aesthetics, and dermatology, Dr. Milligan's expertise in sports medicine and regenerative therapies will be instrumental in driving the development of innovative extracellular vesicle therapeutics.

The details

Dr. Milligan is fellowship-trained and certified in sports medicine, as well as board-certified in family medicine. He has held leadership roles at the Andrews Institute in Florida and in collegiate athletics at UNLV and Northwestern University. In his new role, Dr. Milligan will oversee the advancement of Human Continuum's exosome-based therapies, which aim to deliver regenerative signals to help modulate systemic inflammation and support cellular health.

  • Dr. Milligan was appointed as Chief Medical Officer on February 24, 2026.

The players

Dr. Michael Milligan, MD, MBA

A prominent sports medicine professional with over 25 years of clinical, leadership, and research experience, who has been appointed as the Chief Medical Officer of Human Continuum Inc.

Human Continuum Inc.

A developer of platelet-derived and plant-based exosome therapeutics and diagnostics, focused on advancing next-generation biologic solutions for longevity, orthopedics, aesthetics, and dermatology.

Dr. Sean Law, MD, MBA

The Chief Executive Officer and Board Member of Human Continuum Inc., who welcomed Dr. Milligan to the team.

Got photos? Submit your photos here. ›

What they’re saying

“As medical science continues to improve how we extend both lifespan and quality of life, more people are taking an active interest in their long-term health. I am very pleased to join Dr. Law and Dr. Sial and to apply my decades of clinical and research experience toward advancing extracellular vesicle-based therapeutics and topical formulations. The scientific potential of this technology is significant, and I am excited to contribute to advancing solutions that support healthier, longer lives alongside the Human Continuum team.”

— Dr. Michael Milligan, MD, MBA, Chief Medical Officer of Human Continuum (Human Continuum)

“I am very pleased to welcome Dr. Milligan to the team. Dr. Milligan's hands-on clinical experience, particularly in working with high-performance athletes, brings valuable insight into musculoskeletal health, recovery science, and performance optimization. That perspective will be instrumental as we advance extracellular vesicle–based therapeutics aimed at enhancing long-term health and quality of life for all.”

— Dr. Sean Law, MD, MBA, Chief Executive Officer and Board Member of Human Continuum (Human Continuum)

The takeaway

The appointment of Dr. Michael Milligan, a renowned sports medicine expert, as the Chief Medical Officer of Human Continuum underscores the company's commitment to advancing innovative extracellular vesicle-based therapeutics that can improve long-term health and quality of life for a wide range of patients, from high-performance athletes to the general public.